ArticleThe journal of pathology. Clinical research2024

ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.

Miriam Forster-Sack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.